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Introduction
The accurate localization of small peripheral lung nodules (SPLNs) in a thoracoscopic setting is a challenging task, although video-assisted thoracic surgery (VATS) is a more suitable approach than open surgery for small lesions. 1 In accordance with evolving patient and social demands, the importance of minimally invasive surgical procedures has increased in recent years. In 2010, the rate of VATS reportedly reached nearly 60% of lung cancer surgery in Japan 2 , and 44.7% in the United States. 3 The vast majority of SPLNs are therefore likely to be resected using a thoracoscopic approach in Japan.
Many techniques to assist the localization of SPLNs have been developed and reported; these include finger palpation, percutaneous hook-wire placement, preoperative dye marking, fluoroscopy with a contrast medium, intraoperative ultrasonography (US), and radiotracer-guided surgery. 4 These techniques have proved reliable to a certain extent, but all possess considerable problems in complications, cost, technical difficulty, and availability of facilities. 5 Consequently, there has yet to be an established "best technique", and the choice of method is highly dependent on each surgeon's preference.
Despite the lack of a definitive solution for determining SPLN location, thoracic 7 surgeons are required to manage an increasing number of small pulmonary nodules due to the continued improvement of computed tomography (CT) technology. In 2011, the National Lung Screening Trial established the ability of low-dose CT screening to reduce mortality in a high-risk population. 6 Also, recent guidelines for lung cancer screening from the American Association for Thoracic Surgery have recommended the surgical excision of subcentimeter lesions in cases with suspicious changes in size or appearance. 7 For years, the preoperative marking for lung nodules smaller than 10 mm in size has also been recommended. 8 In light of these advances in CT screening and recommendations, there is an unprecedented need to improve localization techniques. Furthermore, in this era of minimally invasive surgery, there is an increasing demand for innovative localization techniques. An ideal method would not only ensure patient safety but also allow for adequate minimum margins from the lesion. For instance, maintenance of appropriate margins for sub-lobar curative resection of primary lung cancer has been shown to reduce recurrences. 9 The importance of appropriate margins has similarly been emphasized in the resection of metastatic pulmonary nodules to prevent local recurrence. 10 However, in order for surgeons to ensure adequate margins, they must first be able to gauge the exact distance from the target lesion to the cutting line for resection.
To address these problems, we have proposed a novel surgical marking system based on radio frequency identification (RFID) technology, which provides a precise ranging ability. 11
In our system, 13.56 MHz micro RFID tags are used as "wireless surgical markers" to label lesions that are otherwise difficult to locate. In this study, we test the feasibility and reliability of this RFID marking system using experiments with pseudolesions imitating SPLNs in a canine model.
Material and Methods

RFID Marking System
The schematic diagram of our proposed RFID marking system is shown in Figure 1 The detailed composition and algorithms of the system have been reported in our previous paper. 11 The micro RFID tag works as a passive transponder without a built-in battery, with the locating probe acting as both a power supply coil and a receiver antenna. When the probe is placed in close proximity to the tag, the tag is activated by the electromagnetic field produced by the probe. The activated tag returns the response signal with a fixed wavelength of 13.56 ± 0.423 MHz. The distance between the probe and the target tag is measured by signal strength and visually presented on a monitor. The signal strength is also converted to a corresponding audio tone by the signal processing units. The operator can then accurately locate the implanted tags by scanning the target area with the probe and reacting to changes in the tone; when the probe is placed closer to the tag, the system produces a higher pitch. The prototype system used in this animal experiment had an effective range of measurement of 7 mm, and the distance can be measured down to the millimeter level.
Animal Care
Animal care, housing, and surgery were performed with the approval of the Committee for 
Preparation of SPLN-imitating Pseudolesions and Selection of Target Lesions
Prior to the operation, pseudolesions imitating SPLNs were created by injecting 0.2 ml of colored collagen to lung peripheral parenchyma in a selected variety of lobes under CT guidance (Toshiba, Aquilion TSX-101A). The colored collagen solution was prepared as a mixture of 5 ml of 1% collagen solution and 5 ml of dye (5% Indocyanine green or Indigocarmine). A 23G injection needle (Olympus, NM-201L-0423) was used for injecting the solution through the working channel of the bronchoscope (Olympus, BF240). A post-procedure CT scan was performed to confirm the size and location of each created lesion.
Peripherally-located pseudolesions with a diameter of approximately 10 mm were selected as target lesions for further experimentation.
Marking of the Target Lesions
Marking of the target lesions was performed within 2 days after creation for the subsequent operative procedures. Under a CT scan guide, an RFID tag was delivered into a small peripheral airway close to each target lesion. Through the 2 mm working channel of the bronchoscope, an introducer tube with a radiopaque marker on its distal tip was navigated to the target lesion ( Figure 2 ). The tube was constructed from polytetrafluoroethylene (Teflon®), and has an outer diameter of 1.8 mm. When the operator confirmed that the tip of the introducer tube was in the vicinity of the target lesion, the tag could then be implanted: the RFID tag is inserted from the proximal end of the tube and pushed out from the distal end by a flexible pusher-wire made of 12 stainless steel. A post-procedure CT scan was performed to measure the distance from the tag to the nearest edge of the target lesion.
Operative Procedure
Immediately after tag delivery to the target lesions, the dogs were brought into an operation room and placed in a lateral decubitus position. Under general anesthesia with intubation and ipsilateral lung collapse, detection of the embedded tag and wedge resection of the target lesion was conducted. Three ports with 10 mm incision were set for each tag: one for the scope and two for port access to the pleural cavity. Under thoracoscopic view, the lobe of interest was scanned with the locating probe to find the target lesion labeled with the tag. When the tag was localized, ring-shaped forceps were introduced from the other port to grasp the pleura just above the site. Following a re-confirmation of the tag position, the locating probe was pulled off and an endostapler was introduced from the same port to clamp the estimated resection line. Before firing, the locating probe was reinserted in place of the ring forceps to establish that the tag was contained within the lung tissue to be excised ( Figure 3 ). Due to the millimeter-level ranging capability of the system, an appropriate surgical margin could be ensured. When the lesion and 13 the tag were resected with the endostaplers, the specimen was incised in order to measure the surgical margin.
Outcome Measures
The primary endpoint of this study was the rate of successful wedge resection of pseudolesions with good margins. Secondary measures were (1) the distance from the pseudolesion to the tag as shown in the confirmation CT, (2) the time required for the marking procedure, (3) the time required for tag detection at operation, and (4) the distance from the edge of the pseudolesion to the stapler line, which provides information on the surgical margins. The median values and range were calculated for these measures. Finally, we analyzed the system's merits and pitfalls.
Results
A total of 14 pseudolesions were created by colored collagen injection in 7 dogs. Of the 14 pseudolesions, 10 had a diameter of approximately 10 mm and were selected as target lesions for further experimentation; there were two pseudolesions located in the right cranial lobes, four in the right caudal lobes, and four in the left caudal lobes. The other four pseudolesions were 14 excluded because of larger diffusion or intrabronchial spread of injected collagen solution.
Using the bronchoscopic marking procedures, each selected pseudolesion was accurately labeled with one RFID tag (Figure 4) . The tags were placed at a median distance of 2.1 mm from the lesions (range: 0-6.5 mm, confirmed by post-procedure CT scan). The time required for the marking procedure ranged from 5 to 34 minutes (median: 11 minutes) from the insertion of the bronchoscope to the completion of the confirmation CT scan. Marking procedures were performed just after the creation and selection of the first three target pseudolesions, and 1 or 2 days after creation for the other seven. No major complications such as pneumothorax or bleeding were observed.
During the thoracoscopic surgical procedures, nine of the 10 implanted tags were successfully detected by the system. The time required for detection ranged from 10 to 105 seconds (median: 27 seconds). Subsequently, wedge resections were performed for these nine lesions with a median margin of 11 mm (range: 8-12 mm). In the single non-detected case, a right upper lobectomy was performed only to find no tag in the resected lobe. The dislocated tag was later found in the endotracheal tube.
Discussion
RFID is a wireless method of automatic identification originally developed for military radar systems in the 1940s to distinguish between friendly and enemy aircraft. 12 Currently, RFID tags are indispensable in modern society, with applications in item tracking for supply chain management, cashless payments for shopping, and personal identification for ticketing or entrance gates. The continuing miniaturization of RFID tags and development of computer networks have contributed to the widespread use of this system.
Applications have also developed in the field of health care: RFID technology has become widely used for personal identification of medical staff, and tracking drugs and medical equipment in so-called "smart hospitals". 13 Some reports have been published in which RFID technology was deployed to solve problems specific to medical practice. For example, Macario and colleagues 14 successfully detected surgical sponges labeled with RFID tags in the abdomen, Reicher and colleagues 15 reported the efficacious monitoring of the position of an RFID tag-labeled endotracheal tube at bedside, and Mayse and colleagues 16 experimentally implanted RFID tags in canine airways to achieve real-time tracking of tumor positions for stereotactic radiotherapy. In all these medical cases, RFID technology was used to detect the position of an embedded tag.
Our idea was to use micro RFID tags as wireless markers for locating SPLNs in thoracoscopic lung surgery. There is currently only a single previous report by showing a similar concept in the field of breast surgery. 17 That study was essentially a proof of concept in a phantom study using large-sized tags (2 mm in diameter and 8 or 12 mm in length) responding to a radio frequency of 134.2 kHz. To our knowledge, there has been no report on animal experiments or clinical trials of the system, although their tags (VeriChip™, VeriMed) have been approved by the U.S. Food and Drug Administration for human use. With the further advances in RFID technology, we have employed 1 mm-sized RFID tags in this study, and confirmed its feasibility in an animal model for lung wedge resection.
Locating an SPLN has been a challenging task since the era of open thoracotomies. It is even more difficult in a thoracoscopic situation because finger palpation is far less effective.
As a consequence, many techniques to assist in the localization of SPLNs have been innovated, with these techniques broadly belonging to one of two completely different strategies:
Intraoperative techniques (e.g., finger palpation and ultrasound) and preoperative placement of a marker (e.g., hook-wire, dye, contrast medium, and radiotracer). 4 Intraoperative techniques have the virtue of non-invasiveness, and to our knowledge no major complications as a result of these techniques have been reported. Even though intraoperative US is more effective than finger palpation with success rate of 70-100 % in selected patients 4 , this technique has several limitations. 5 Successful localization using intraoperative US is highly dependent on operator skill. Also, localization is difficult in cases of emphysematous change or incomplete collapse of the target lung. Success rates are further reduced in cases of small nodules less than 1 cm in size or deep lesions more than 1 cm from the visceral pleura. Soft nodular ground-glass opacities observed in bronchoalveolar cell carcinomas are also difficult to localize using US. Because of these limitations, intraoperative US has little versatility as a localization technique.
The use of markers is a viable option for surgeons to overcome the limitations of intraoperative localization techniques. The implantation or delivery procedures of several kinds of markers can be classified to two categories according to their approaches: a percutaneous pneumocentesis approach and a transbronchial approach with bronchoscope. Generally, percutaneous implantation of a marker is highly associated with complications such as pneumothorax (8-50%), pulmonary hemorrhage (12-35%), and pleuritic pain (5-6%). 4 In addition, several authors have raised caution on the risk of fatal air embolisms induced by hook-wire implantation. 18 In contrast, the transbronchial approach can theoretically eliminate the risk of complications related to the percutaneous approach. In our experiments, no major complications were observed related to bronchoscopic delivery of RFID tags, and the time required for marking ranged from 5 to 34 minutes (median: 11 minutes). Bronchoscopic procedures can be a distressing experience for patients, but the transbronchial approach is less invasive when compared with the percutaneous approach.
However, some markers have been used in spite of their negative aspects. Time constraints are the main cause of failure in the case of dye or radiotracer marking, as the diffusion of dyes and the decay of radiotracers prevent surgeons from successful localization of SPLNs. These shortcomings also lead to difficulties in scheduling preoperative procedures and surgical resection. It has been recommended that surgery be performed within 24 hours after injection of dye, and within 12 hours after radiotracer administration. [4] [5] The RFID marking system is free from these time constraints and can provide flexibility in the time-interval between marking procedure and surgery.
In the context of intraoperative fluoroscopy, a contrast medium (i.e. barium or lipiodol) is consistently reported as the most effective and reliable marker: Watanabe and colleagues 19 reported a success rate of 100% from their experience of 174 nodules; Asano et al. 20 emphasized a success rate of 100% for 31 pure ground-glass nodules less than 10 mm in size; and Okumura et al. 21 stated that good surgical margins could be assured with this technique, and that multiple markings can be achieved by transbronchial injection of barium with minimum invasiveness. Unfortunately, despite these merits, the radiation exposure for operators and patients cannot be overlooked. Unnecessary exposure to medical radiation should be avoided if possible, and the use of RFID technology presents an alternative for the purpose of SPLN localization. The RFID marking system has several positive aspects. The first merit is that of quick detection with simple operability. The system requires only a locating probe in the surgical field. During thoracoscopic surgical procedures, localization of the RFID tag was promptly achieved without the need for unwieldy instruments such as a fluoroscope. As shown in our experiments, the time required for tag detection after insertion of the locating probe ranged from 10 to 105 seconds (median: 27 seconds). Quick detection of the tag and swift localization of the target lesion were achieved by simply listening and reacting to the audio cues 20 from the system; there was no need for operators to shift their gaze from the surgical field or the monitor for the thoracoscope. The simple operability of the system also exempts thoracic surgeons from having to become skilled in an unfamiliar technique such as US interpretation, or from the threat of radiation exposure. The second and more important merit is that the 1 mm-sized small wireless marker enables the pinpoint localization of target lesions; the system provides millimeter-level ranging capability to enhance localization accuracy. As a consequence, an appropriate distance from the lesion to the resection line is ensured because the operator can confirm that the RFID marker is included within the lung parenchyma to be resected. In our study with pseudolesions, surgical margins of resected specimens ranged from 8 to 12 mm (median: 11 mm). Accurate localization enables thoracic surgeons to perform sub-lobar resections with reduced risk of local recurrence in a short procedure time. Thirdly, the labeling of multiple lesions or multiple marking of a single lesion can be achieved in this system because each tag has its own unique identifiable number.
This study has the following limitations. Our prototype system has an effective communication range of 7 mm, mainly due to limitations in the power supply from the locating probe. Although 7 mm is adequate for animal experiments, an effective range of 30 mm may be required for clinical use in human lungs. Improvements to the effective range are in progress and can be achieved with further customization of the tag and the probe.
The second limitation is that dislocation of the implanted tag is a problem of critical importance for the RFID marking system. The reason for the sole detection failure in our experiments was the dislocation of the tag to the central airway. To address this problem, a tag anchoring function is under development. For the purpose of lung tumor tracking during radiation therapy, the use of an RFID tag with anchoring legs was reported to have an 87% successful stabilization rate for a period of 60 days. 22 In addition to the anchoring function, the coating of RFID tags is another modification under consideration due to the possibility of accidental ingestion of a dislocated tag into the digestive tract.
The third limitation is related to the safety of the system. We did not encounter any instances of adverse effects caused by the tag, but the study period was limited to 3 days at its longest. The safety of the in-vivo use of RFID tags has been endorsed by long-term experiments in a canine subcutaneous implantation model 23 , as well as by routine use in livestock farming.
Although we have had limited experience with RFID tag placement into a small airway, Mayse et al. 16 have reported no complications in similar experimental implantation of 60 days. To our knowledge, no other published report has described the long-term implantation effects of RFID tags into airways. Further investigation is therefore required into the safety of this system.
The additional cost, time, and radiation exposure could be a demerit of this new method. However, the preoperative marking procedure under CT guidance may be appropriate for cases where the target is a small peripheral lesion that is difficult to locate under fluoroscopy.
The use of navigational bronchoscopy technique may assist in the accurate delivery of RFID tags, while reducing cost, time, and exposure. RFID tags in commercial mass production are expected to be similar in cost to conventional markers including hookwires or dye. In general, we estimate that the additional cost, time, and radiation exposure for the RFID marking method may be in the same range as conventional methods that require CT guidance. A cost-benefit analysis is required to determine the best role and use of such techniques in the overall management of small peripheral lung nodules.
Conclusion
23
The feasibility of our RFID marking system for SPLN localization was demonstrated in a canine model. Further developmental work is underway to improve the effective range, to equip the tags with an anchoring function, and to confirm the safety in implantation. to audio cues; when the probe is nearer the tag, the system produces a higher pitch. Figure 2 . Illustration of the RFID tag delivery system. An introducer tube with a radiopaque marker on its distal tip is inserted through the 2 mm channel of a bronchoscope. The material of the tube is polytetrafluoroethylene (Teflon®). An RFID tag is inserted from the proximal end of the tube and pushed out from the distal end by a pusher-wire. 28 Table 1 . Results of the primary endpoint and secondary outcome measures of the experiments.
Figure Legends
Primary endpoint
Successful tag detection* 9 / 10
Successful wedge resection* 9 / 10
Secondary measures Median
Time required for marking (minutes) 5 -34 11
Distance from the lesion to the tag (mm) 0 -6. 
